Who owns QUINCE THERAPEUTICS INC COM?
- CUSIP Number: 22053a305
Tip: Access positions for across all investors
Analyze quarterly positions in Quince Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Quince Therapeutics stock
Who bought or sold QUINCE THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 12k | $219k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 3.6k | $66k | 100% | Jun 2026 |
|
| Tower Research Capital | 567.00 | $10k | 100% | Jun 2026 |
|
| Integrated Wealth Concepts | 12.00 | $218.000400 | 100% | Jun 2026 |
|
| Hanson McClain Advisors | 8.00 | $137.000000 | 100% | Jun 2026 |
|
| Mercer Global Advisors | 6.00 | $109.000200 | 100% | Jun 2026 |
|
| Parallel Advisors | 3.00 | $54.999900 | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 2.00 | $2.000000 | 100% | Jun 2026 |
|